Allurion converts $7.5M equity investment into revenue interest financing with RTW

ALLURION TECHNOLOGIES, INC.

Entered Revenue Interest Financing Agreement (New RIFA) on Oct 30, 2024, converting $7.5M of prior equity purchase into financing.
Financing parties: RTW Master Fund, RTW Innovation Master Fund, RTW Biotech Opportunities Operating Ltd.
New RIFA terms substantially identical to Original RIFA dated Feb 9, 2023; conversion exercised under Side Letter.
Conversion triggered by Oct 22, 2024 election by RTW entities to exercise Investment Conversion in full.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.